Italian researchers report that severe fibrosis increases the early atherosclerosis risk in patients with genotype 1 chronic hepatitis C virus (HCV) infection. A second study found that fatty liver disease also increases ...
Apr 24, 2012
0
0
New research confirms that a variant on the patatin-like phospholipase-3 (PNPLA3) gene increases risk of steatosis and fibrosis progression in patients with chronic hepatitis C virus (HCV). The PNPLA3 single nucleotide polymorphism ...
Jun 28, 2011
0
0
Vitamin D plays a large role in overall health, but it can be challenging to absorb sufficient levels—especially in the colder months. A Baylor College of Medicine expert provides tips on how to maintain your vitamin D ...
Nov 10, 2023
0
25
In research published in The FASEB Journal, scientists have discovered that a molecule called Yes-associated protein (YAP) plays a key role in the development of liver scarring, or fibrosis, by influencing the behavior of ...
Apr 19, 2023
0
3
Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent chronic liver disorders worldwide and can sometimes lead to severe conditions like cirrhosis and hepatocellular carcinoma. As such, early assessment of ...
Jun 2, 2022
0
33
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, found a link between larger waistlines and the progression of non-alcoholic fatty liver ...
Sep 30, 2021
0
4
Research by the University of Valencia, CIBERehd and FISABIO offers an exhaustive analysis of the different published studies on autophagy, a cellular process involved in liver fibrosis. The work addresses the different aspects ...
Jul 1, 2021
0
2
A team of scientists from Immanuel Kant Baltic Federal University together with their colleagues from NUST MISiS and RWTH Aachen University (Germany) compared different treatments against liver fibrosis and published the ...
Jan 21, 2020
0
3
With an estimated 25% of people worldwide affected by nonalcoholic fatty liver disease (NAFLD), there is a large unmet need for accurate, noninvasive measures to enhance early diagnosis and screening of hepatic fibrosis. ...
Apr 16, 2019
0
2
AKR1B10 is a useful serum biomarker for advanced liver fibrosis in Nonalcoholic steatohepatitis, and combined with serum WFA(+)-M2BP, it can predict hepatocellular carcinoma development, gastroesophageal varix formation, ...
Apr 12, 2019
0
0
